The Endocrine Society has concerns of possible delays in care and other problematic areas of The Lancet Commission’s proposed new obesity framework; a Commission author cites ‘conceptual confusions.’ ...
Neurocrine Biosciences has agreed to acquire Soleno Therapeutics for $2.9 billion, the companies said, in a deal designed to bolster the buyer’s portfolio of marketed endocrinology and rare disease ...
More than tripled risk of five-year mortality seen with use of complementary and alternative medicine alone compared with traditional therapies.
As First Hub Opens, Tekton Adds New Principal Investigator, Dr. Arti Thangudu, and Expands Patient Access to Clinical Research ...
Some say it’s ‘bad medicine’ not to be prescribing it more to high-risk patients, whereas others think alternative approaches might be better.
MedPage Today on MSN
Heart Risks After GLP-1 Hiatus; TED Drug Success; Top Diabetes Researcher Dies
News and commentary from the endocrinology world ...
For centuries, mental illness and physical disease have been viewed as two distinct categories, each with its own field of ...
MedPage Today on MSN
GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics
News and commentary from the endocrinology world ...
Sitting above each kidney are two small endocrine glands about the size of walnuts. These are the adrenal glands, responsible ...
Adenomyosis is characterized by the presence of endometrial glands within the myometrium and has a reported prevalence ...
Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health problems may complicate diagnosis and delay treatment, according to an Endocrine ...
Aspect Biosystems has secured a C$79m($56.6m) investment from the Government of Canada to support a C$280m multi-year project ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results